ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

52 hedge funds and large institutions have $196M invested in Adamas Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$1.65M
2 -$1.64M
3 -$890K
4
BlackRock
BlackRock
New York
-$393K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$241K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$417K
27
$410K
28
$317K
29
$302K
30
$254K
31
$232K
32
$216K
33
$213K
34
$210K
35
$201K
36
$165K
37
$148K
38
$93K
39
$72K
40
$38K
41
$34K
42
$31.9K
43
$26K
44
$20K
45
$14K
46
$10K
47
$7K
48
$4K
49
$2K
50
$2K